About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05372055

Malignant Pleural Effusions: Evaluating the psYchosocial Impact of Indwelling Pleural Catheters on Patients

The purpose of this study is to better understand the impact that Indwelling Pleural Catheters have on patients with malignant pleural effusions from a psychosocial point of view.

Lead sponsor: Guy's and St Thomas' NHS Foundation Trust•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Guy's and St Thomas' NHS Foundation Trust

After being informed about the study, all patients giving written informed consent will undergo a baseline assessment including disease and social characteristics on the day of their Indwelling Pleural Catheter (IPC) insertion. At 2 weeks and 6-8 weeks post insertion, they will be contacted via telephone for a semi-structured interview focusing on the psychosocial impact that the IPC has had on their lives. Data surrounding the medical care of the IPC will also be collected.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participant is willing and able to give informed consent for participation in the study
•Aged 18 years or above
•Diagnosis of malignant pleural effusion
•Will be undergoing IPC insertion for management of their malignant pleural effusion
•Have the means to be contacted and be able to conduct an interview in English via telephone within the study timeframe

Exclusion Criteria

•Inability to consent
•Estimated life expectancy of \<4 weeks

Related studies

UNC Pleural Fluid Registry

NCT05620329 · Lung Cancer, Lung Infection, and more

Impact of Pleural Manometry on the Assessment and Treatment of Malignant Pleural Effusion: A Pilot Clinical Trial

NCT07120867 · Malignant Pleural Effusions (Mpe)

RECRUITINGPhase 1

Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer

NCT06016179 · Malignant Pleural Effusion, Malignant Ascites

Feasibility of Ambulatory Talc. Pleurodesis

NCT06682936 · Malignant Pleural Effusion, Malignancy, and more

RECRUITINGPhase 1

OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.

NCT06421610 · Malignant Pleural Effusion, Pleural Neoplasms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 9, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment18

Start dateMay 2022

Last updatedJun 9, 2023

Condition

Malignant Pleural Effusion Indwelling Pleural Catheter

Locations shown

Guy's & St Thomas' NHS Foundation Trust

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 9, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions